Form4insider filings, from the source

SEC Form 4 · accession 0000921895-16-004949

Enveric Biosciences, Inc. · ENVB

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Jeffrey E. Eberwein
Director · 10% Owner
Period of report
Jun 7, 2016
Accepted (ET)
Jun 15, 2016 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F5Jun 7, 2016L9$6.51A41,592IBy: Separately Managed Account
Common StockF1,F5Jun 13, 2016P1,000$6.51A42,592IBy: Separately Managed Account
Common StockF1,F5Jun 14, 2016P84$6.51A42,676IBy: Separately Managed Account
Common StockF1,F2holding———1,666,755IBy: Lone Star Value Investors, LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses